SCHEMBL5257150

SCHEMBL5257150

CCNc1nccc(-c2cc(OC(=O)O)c(=O)[nH]n2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ AKT3 Q9Y243 1/20 0.36
▸ BRAF P15056 2/20 0.35
▸ MKNK1 Q9BUB5 1/20 0.35
▸ CDC7 O00311 3/20 0.34
▸ EIF2AK2 P19525 2/20 0.34
▸ PIK3CA P42336 1/20 0.33
▸ DYRK1A Q13627 2/20 0.33
▸ CLK4 Q9HAZ1 2/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ AURKA O14965 2/20 0.32
▸ AURKB Q96GD4 2/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CDK7 P50613 1/20 0.32
▸ CDK9 P50750 1/20 0.32
▸ VCP P55072 1/20 0.32
▸ TTK P33981 1/20 0.32
▸ INCENP Q9NQS7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254880 0.88 GSK3B (0.42) PDPK1GSK3BAKT3BRAFMKNK1
SCHEMBL2947276 0.83 GSK3B (0.52) PDPK1GSK3BAKT3BRAFMKNK1
SCHEMBL5234145 0.82 DYRK1A (0.44) PDPK1GSK3BAKT3BRAFDYRK1A
SCHEMBL5253672 0.80 PDPK1 (0.39) PDPK1GSK3BAKT3BRAFHDAC1
SCHEMBL2946867 0.79 GSK3B (0.49) PDPK1GSK3BKMT2ANPSR1
SCHEMBL4857179 0.72 GSK3B (0.65) PDPK1GSK3BCDC7EIF2AK2
SCHEMBL5235357 0.72 GSK3B (0.66) GSK3BEIF2AK2DYRK1ACLK4HDAC1
SCHEMBL4853882 0.72 GSK3B (0.55) GSK3BAKT3DYRK1ACLK4AURKA
SCHEMBL5237798 0.71 AKT3 (0.44) GSK3BAKT3BRAFDYRK1ACLK4
SCHEMBL5230846 0.71 GSK3B (0.76) GSK3BEIF2AK2DYRK1ACLK4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725543-B1 4-BENZIMIDAZOL-2-YL-PYRIDAZINE-3-ONE-DERIVATIVES, PRODUCTION AND USE THEREOF IN MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-28 — — EP disclosed
Send feedback